Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, September 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,067 followers.

Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer. https://t.co/yYYN6DLrA3 h/t @NCBI #RadOnc #PubMed

07 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.